Subretinal timrepigene emparvovec in adult men with choroideremia: a randomized phase 3 trial - MacLaren, RE; Fischer, MD; Gow, JA; Lam, BL; Sankila, E-MK; Girach, A; Panda, S; Yoon, D; Zhao, G; Pennesi, ME (Nature Medicine, 2023)